PURCELL MICHAEL J. purchased 160.0% of their position (2M shares) of HEPION PHARMACEUTICALS, INC. on the open market
Open‑market purchase worth $100.0K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 8/13/2026ACC: 0001493152-26-037493
Director
Since Mar 2024
+4M
Net shares
Net buyer
$100.0K
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
4M acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+2M
Price / share
$0.05
Trade value
$100K
% of position
160.0%
8/3/2026
1.25M→3.25M
Total
Net shares
+2M
Net value
$100K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/3/2026 | P · Purchase | +2M | $0.05 | $100K | 160.0% | 1.25M | 3.25M |
| Total | +2M | $100K | ||||||
Derivative Transactions1
Warrants
Direct
Converts to
Common Stock
2M shares
Shares
+2M
Strike price
0.06
Held after
2M
Exercisable
—
8/3/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Warrants Direct | Common Stock2M shares | 8/3/2026 | P · Purchase | +2M | 0.06 | — | 2M |